A one-standarddeviation increment in circulating bilirubin (≈ 4.4 μmol/L), predicted by non-UGT1A1 SNPs, was inversely associated with risk of squamous cell lung cancer and Hodgkin’s lymphoma (odds ratio (OR) 0.85, 95% confidence interval (CI) 0. The gene discussed is UGT1A1; the disease is Hodgkins lymphoma.